The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders

  1. Cheen Euong Ang
  2. Qing Ma
  3. Orly L Wapinski
  4. ShengHua Fan
  5. Ryan A Flynn
  6. Qian Yi Lee
  7. Bradley Coe
  8. Masahiro Onoguchi
  9. Victor Hipolito Olmos
  10. Brian T Do
  11. Lynn Dukes-Rimsky
  12. Jin Xu
  13. Koji Tanabe
  14. LiangJiang Wang
  15. Ulrich Elling
  16. Josef M Penninger
  17. Yang Zhao
  18. Kun Qu
  19. Evan E Eichler
  20. Anand Srivastava
  21. Marius Wernig  Is a corresponding author
  22. Howard Y Chang  Is a corresponding author
  1. Stanford University, United States
  2. Greenwood Genetic Center, United States
  3. Howard Hughes Medical Institute, University of Washington, United States
  4. Clemson University, United States
  5. Institute of Molecular Biotechnology of the Austrian Academy of Science, Austria

Abstract

Long noncoding RNAs (lncRNAs) have been shown to act as important cell biological regulators including cell fate decisions but are often ignored in human genetics. Combining differential lncRNA expression during neuronal lineage induction with copy number variation morbidity maps of a cohort of children with autism spectrum disorder/intellectual disability versus healthy controls revealed focal genomic mutations affecting several lncRNA candidate loci. Here we find that a t(5:12) chromosomal translocation in a family manifesting neurodevelopmental symptoms disrupts specifically lnc-NR2F1. We further show that lnc-NR2F1 is an evolutionarily conserved lncRNA functionally enhances induced neuronal cell maturation and directly occupies and regulates transcription of neuronal genes including autism-associated genes. Thus, integrating human genetics and functional testing in neuronal lineage induction is a promising approach for discovering candidate lncRNAs involved in neurodevelopmental diseases.

Data availability

Sequencing data have been deposited in GEO under accession code GSE115079.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Cheen Euong Ang

    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Qing Ma

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Orly L Wapinski

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. ShengHua Fan

    J C Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ryan A Flynn

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Qian Yi Lee

    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9200-0910
  7. Bradley Coe

    Department of Genome Sciences, Howard Hughes Medical Institute, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Masahiro Onoguchi

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Victor Hipolito Olmos

    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Brian T Do

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Lynn Dukes-Rimsky

    J C Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Jin Xu

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0944-9835
  13. Koji Tanabe

    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. LiangJiang Wang

    Department of Genetics and Biochemistry, Clemson University, Clemson, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Ulrich Elling

    Vienna Biocenter, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  16. Josef M Penninger

    Vienna Biocenter, Institute of Molecular Biotechnology of the Austrian Academy of Science, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8194-3777
  17. Yang Zhao

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Kun Qu

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Evan E Eichler

    Department of Genome Sciences, Howard Hughes Medical Institute, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8246-4014
  20. Anand Srivastava

    J C Self Research Institute of Human Genetics, Greenwood Genetic Center, Greenwood, United States
    Competing interests
    The authors declare that no competing interests exist.
  21. Marius Wernig

    Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States
    For correspondence
    wernig@stanford.edu
    Competing interests
    The authors declare that no competing interests exist.
  22. Howard Y Chang

    Center for Personal Dynamic Regulomes, Stanford University, Stanford, United States
    For correspondence
    howchang@stanford.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9459-4393

Funding

NIH Office of the Director (RC4-NS073015)

  • Marius Wernig
  • Howard Y Chang

NIH Office of the Director (P50-HG007735)

  • Howard Y Chang

California Institute for Regenerative Medicine

  • Marius Wernig
  • Howard Y Chang

NIH Office of the Director (RO1-HD39331)

  • Anand Srivastava

Self Regional Healthcare Foundation

  • Anand Srivastava

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All mouse work was performed according to IACUC approved protocols at Stanford University (APLAC-21565). Samples in the paper were obtained without determining their sex. All animals were housed in an animal facility with a 12hr light/dark cycle.

Human subjects: The study protocol, consent form, consent to publish and privacy practices were reviewed and approved by the Institutional Review Board of the Self Regional Healthcare, Greenwood, SC (Reference number Pro00074882).

Copyright

© 2019, Ang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,485
    views
  • 869
    downloads
  • 60
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Cheen Euong Ang
  2. Qing Ma
  3. Orly L Wapinski
  4. ShengHua Fan
  5. Ryan A Flynn
  6. Qian Yi Lee
  7. Bradley Coe
  8. Masahiro Onoguchi
  9. Victor Hipolito Olmos
  10. Brian T Do
  11. Lynn Dukes-Rimsky
  12. Jin Xu
  13. Koji Tanabe
  14. LiangJiang Wang
  15. Ulrich Elling
  16. Josef M Penninger
  17. Yang Zhao
  18. Kun Qu
  19. Evan E Eichler
  20. Anand Srivastava
  21. Marius Wernig
  22. Howard Y Chang
(2019)
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders
eLife 8:e41770.
https://doi.org/10.7554/eLife.41770

Share this article

https://doi.org/10.7554/eLife.41770

Further reading

    1. Developmental Biology
    2. Genetics and Genomics
    Anne-Sophie Pepin, Patrycja A Jazwiec ... Sarah Kimmins
    Research Article Updated

    Paternal obesity has been implicated in adult-onset metabolic disease in offspring. However, the molecular mechanisms driving these paternal effects and the developmental processes involved remain poorly understood. One underexplored possibility is the role of paternally induced effects on placenta development and function. To address this, we investigated paternal high-fat diet-induced obesity in relation to sperm histone H3 lysine 4 tri-methylation signatures, the placenta transcriptome, and cellular composition. C57BL6/J male mice were fed either a control or high-fat diet for 10 weeks beginning at 6 weeks of age. Males were timed-mated with control-fed C57BL6/J females to generate pregnancies, followed by collection of sperm, and placentas at embryonic day (E)14.5. Chromatin immunoprecipitation targeting histone H3 lysine 4 tri-methylation (H3K4me3) followed by sequencing (ChIP-seq) was performed on sperm to define obesity-associated changes in enrichment. Paternal obesity corresponded with altered sperm H3K4me3 at promoters of genes involved in metabolism and development. Notably, altered sperm H3K4me3 was also localized at placental enhancers. Bulk RNA-sequencing on placentas revealed paternal obesity-associated sex-specific changes in expression of genes involved in hypoxic processes such as angiogenesis, nutrient transport, and imprinted genes, with a subset of de-regulated genes showing changes in H3K4me3 in sperm at corresponding promoters. Paternal obesity was also linked to impaired placenta development; specifically, a deconvolution analysis revealed altered trophoblast cell lineage specification. These findings implicate paternal obesity effects on placenta development and function as one potential developmental route to offspring metabolic disease.

    1. Biochemistry and Chemical Biology
    2. Genetics and Genomics
    Federico A Vignale, Andrea Hernandez Garcia ... Adrian G Turjanski
    Research Article

    Yerba mate (YM, Ilex paraguariensis) is an economically important crop marketed for the elaboration of mate, the third-most widely consumed caffeine-containing infusion worldwide. Here, we report the first genome assembly of this species, which has a total length of 1.06 Gb and contains 53,390 protein-coding genes. Comparative analyses revealed that the large YM genome size is partly due to a whole-genome duplication (Ip-α) during the early evolutionary history of Ilex, in addition to the hexaploidization event (γ) shared by core eudicots. Characterization of the genome allowed us to clone the genes encoding methyltransferase enzymes that catalyse multiple reactions required for caffeine production. To our surprise, this species has converged upon a different biochemical pathway compared to that of coffee and tea. In order to gain insight into the structural basis for the convergent enzyme activities, we obtained a crystal structure for the terminal enzyme in the pathway that forms caffeine. The structure reveals that convergent solutions have evolved for substrate positioning because different amino acid residues facilitate a different substrate orientation such that efficient methylation occurs in the independently evolved enzymes in YM and coffee. While our results show phylogenomic constraint limits the genes coopted for convergence of caffeine biosynthesis, the X-ray diffraction data suggest structural constraints are minimal for the convergent evolution of individual reactions.